[
  {
    "ts": "2025-12-29T13:00:00+00:00",
    "headline": "Johnson & Johnson completes acquisition of Halda Therapeutics and its novel platform to revolutionize cancer treatment and enable next-generation oral therapies",
    "summary": "NEW BRUNSWICK, N.J., December 29, 2025--Johnson & Johnson (NYSE: JNJ) (the \"Company\") today announced the successful completion of its acquisition of Halda Therapeutics OpCo, Inc. (\"Halda\"), a clinical-stage biotechnology company with a proprietary Regulated Induced Proximity TArgeting Chimera (RIPTAC™) platform to develop oral, targeted therapies for multiple types of solid tumors, including prostate cancer, for $3.05 billion in cash.",
    "url": "https://finance.yahoo.com/news/johnson-johnson-completes-acquisition-halda-130000252.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "6ffefa02-5f39-37cc-a1f8-57464edfb851",
      "content": {
        "id": "6ffefa02-5f39-37cc-a1f8-57464edfb851",
        "contentType": "STORY",
        "title": "Johnson & Johnson completes acquisition of Halda Therapeutics and its novel platform to revolutionize cancer treatment and enable next-generation oral therapies",
        "description": "",
        "summary": "NEW BRUNSWICK, N.J., December 29, 2025--Johnson & Johnson (NYSE: JNJ) (the \"Company\") today announced the successful completion of its acquisition of Halda Therapeutics OpCo, Inc. (\"Halda\"), a clinical-stage biotechnology company with a proprietary Regulated Induced Proximity TArgeting Chimera (RIPTAC™) platform to develop oral, targeted therapies for multiple types of solid tumors, including prostate cancer, for $3.05 billion in cash.",
        "pubDate": "2025-12-29T13:00:00Z",
        "displayTime": "2025-12-29T13:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/0f0b62a9f4b1e13b2aa5af2e1cdf3b63",
          "originalWidth": 2404,
          "originalHeight": 224,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/weLe3qptfKXPWj9MJ5v7jg--~B/aD0yMjQ7dz0yNDA0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/0f0b62a9f4b1e13b2aa5af2e1cdf3b63.cf.webp",
              "width": 2404,
              "height": 224,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Ql9Yuwq8VqEQAbs6LfWzhA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/0f0b62a9f4b1e13b2aa5af2e1cdf3b63.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/johnson-johnson-completes-acquisition-halda-130000252.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/johnson-johnson-completes-acquisition-halda-130000252.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]